Julintorn Somran

Julintorn Somran

Auto-generated profile, based on publicly available information

Julintorn Somran

Department of Pathology, Faculty of Medicine, Naresuan University, Phitsanulok, 65000, Thailand

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TWThanwarat Winitchaikul
Thanwarat Winitchaikul
SSSuphunwadee Sawong
Suphunwadee Sawong
DSDamratsamon Surangkul
Damratsamon Surangkul
MSMetawee Srikummool
Metawee Srikummool
JSJulintorn Somran
Julintorn Somran
PSPiyarat Srisawang
Piyarat Srisawang
Conventional chemotherapeutic agents for colorectal cancer (CRC) cause systemic side effects and eventually become less efficacious owing to the development of drug resistance in cancer cells. Therefore, new therapeutic regimens have focused on the use of natural products. The anticancer activity of several parts ofCalotropis giganteahas been reported; however, the effects of its stem bark extract on inhibition of cancer cell proliferation have not yet been examined. In this study, the anticancer activity ofC.giganteastem bark extract, both alone and in combination with 5-fluorouracil (5-FU), was evaluated. A crude ethanolic extract was prepared from dry, powderedC.giganteabarks using 95% ethanol. This was then partitioned to obtain dichloromethane (CGDCM), ethyl acetate, and water fractions. Quantitative analysis of the constituent secondary metabolites and calotropin was performed. These fractions exhibited cytotoxicity in HCT116 and HT-29 cells, with CGDCM showing the highest potency in both the cell lines. A combination of CGDCM and 5-FU significantly enhanced the cytotoxic effect. Moreover, the resistance of normal fibroblast, HFF-1, cells to this combination demonstrated its safety in normal cells. The combination significantly enhanced apoptosis through the mitochondria-dependent pathway. Additionally, the combination reduced adenosine triphosphate production and increased the production of reactive oxygen species, demonstrating the mechanisms involved in the induction of apoptosis. Our results suggest that CGDCM is a promising anti-cancer agent and may enhance apoptosis induction by 5-FU in the treatment of CRC, while minimizing toxicity toward healthy cells.

15 July 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SSSuphunwadee Sawong
Suphunwadee Sawong
DPDumrongsak Pekthong
Dumrongsak Pekthong
PSPennapha Suknoppakit
Pennapha Suknoppakit
TWThanwarat Winitchaikul
Thanwarat Winitchaikul
WKWorasak Kaewkong
Worasak Kaewkong
PSPiyarat Srisawang
Piyarat Srisawang
Several fractions ofCalotropis giganteaextracts have been proposed to have potential anticancer activity in many cancer models. The present study evaluated the anticancer activity ofC. giganteastem bark extracts in liver cancer HepG2 cells and diethylnitrosamine (DEN)-induced primary liver cancer in rats. The carcinogenesis model induced by DEN administration has been widely used to study pathophysiological features and responses in rats that are comparable to those seen in cancer patients. The dichloromethane (CGDCM), ethyl acetate, and water fractions obtained from partitioning crude ethanolic extract were quantitatively analyzed for several groups of secondary metabolites and calactin contents. A combination ofC. giganteastem bark extracts with doxorubicin (DOX) was assessed in this study to demonstrate the enhanced cytotoxic effect to cancer compared to the single administration. The combination of DOX and CGDCM, which had the most potential cytotoxic effect in HepG2 cells when compared to the other three fractions, significantly increased cytotoxicity through the apoptotic effect with increased caspase-3 expression. This combination treatment also reduced ATP levels, implying a correlation between ATP and apoptosis induction. In a rat model of DEN-induced liver cancer, treatment with DOX,C. giganteaat low (CGDCM-L) and high (CGDCM-H) doses, and DOX + CGDCM-H for 4 weeks decreased the progression of liver cancer by lowering the liver weight/body weight ratio and the occurrence of liver hyperplastic nodules, fibrosis, and proliferative cells. The therapeutic applications lowered TNF-α, IL-6, TGF-β, and α-SMA inflammatory cytokines in a similar way, implying that CGDCM had a curative effect against the inflammation-induced liver carcinogenesis produced by DEN exposure. Furthermore, CGDCM and DOX therapy decreased ATP and fatty acid synthesis in rat liver cancer, which was correlated with apoptosis inhibition. CGDCM reduced cleaved caspase-3 expression in liver cancer rats when used alone or in combination with DOX, implying that apoptosis-inducing hepatic carcinogenesis was suppressed. Our results also verified the low toxicity of CGDCM injection on the internal organs of rats. Thus, this research clearly demonstrated a promising, novel anticancer approach that could be applied in future clinical studies of CGDCM and combination therapy.

6 July 2023 in Heliyon
Verified
Journal Article
Open access
OSOrakot Simanurak
Orakot Simanurak
DPDumrongsak Pekthong
Dumrongsak Pekthong
JSJulintorn Somran
Julintorn Somran
AWApirath Wangteeraprasert
Apirath Wangteeraprasert
MSMetawee Srikummool
Metawee Srikummool
PSPiyarat Srisawang
Piyarat Srisawang
Calotropis gigantea stem bark extract, particularly the dichloromethane fraction (CGDCM), demonstrated the most potent antiproliferative effects on hepatocellular carcinoma HepG2 and colorectal HCT116 cells. The current study focused on enhancing the effectiveness of cancer treatment with CGDCM at concentrations close to the IC50 in HCT116 cells by reducing their nutrient supply. CGDCM (2, 4, and 8 μg/mL) treatment for 24 h under glucose conditions of 4.5 g/L without fetal bovine serum (FBS) supplementation or serum starvation (G+/F−), glucose 0 g/L with 10% FBS or glucose starvation (G−/F+), and glucose 0 g/L with 0% FBS or complete starvation (G−/F−) induced a greater antiproliferative effect in HCT116 cells than therapy in complete medium with glucose 4.5 g/L and 10% FBS (G+/F+). Nonetheless, the anticancer effect of CGDCM at 4 μg/mL under (G−/F−) showed the highest activity compared to other starvation conditions. The three starvation conditions showed a significant reduction in cell viability compared to the control (G+/F+) medium group, while the inhibitory effect on cell viability did not differ significantly among the three starvation conditions. CGDCM at 4 μg/mL in (G−/F−) medium triggered apoptosis by dissipating the mitochondrial membrane potential and arresting cells in the G2/M phase. This investigation demonstrated that a decrease in intracellular ATP and fatty acid levels was associated with enhanced apoptosis by treatment with CGDCM at 4 μg/mL under (G−/F−) conditions. In addition, under (G−/F−), CGDCM at 4 μg/mL increased levels of reactive oxygen species (ROS) and was suggested to primarily trigger apoptosis in HCT116 cells. Thus, C. gigantea extracts may be useful for the future development of alternative, effective cancer treatment regimens.

4 July 2024 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
THThaiyawat Haewphet
Thaiyawat Haewphet
SPSupawadee Parhira
Supawadee Parhira
PCPattaraporn Chaisupasakul
Pattaraporn Chaisupasakul
AWApirath Wangteeraprasert
Apirath Wangteeraprasert
IPIttipon Phoungpetchara
Ittipon Phoungpetchara
PSPiyarat Srisawang
Piyarat Srisawang